Symbol Lookup

Saturday October 25, 2014 2:56 PM ET. Data delayed 15 minutes.
8.16
-0.02 (-0.24%)
Bid/Lots
8.13/1
Ask/Lots
8.16/9
Open/Prev Close
8.20/8.18
Day Range
7.87-8.20
52-Week Range
7.53-23.25
Vol/Avg Daily Vol
57.5K/49.0K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
No documents available

Peers Headlines

Oct 22, 2014

Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma
8:45AM ET on Wednesday Oct 22, 2014 by PR Newswire
Companies Mentioned: PGNX, THLD, IDRA, MACK, FOLD

Investor-Edge has initiated coverage on the following equities: Amicus Therapeutics Inc. (NASDAQ: FOLD), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX), Threshold Pharmaceuticals Inc. (NASDAQ: THLD), Idera Pharmaceuticals Inc. (NASDAQ: IDRA), an...

Oct 16, 2014

NeoStem, Inc. - "A View from the Front Line of Clinical Investigation"
8:17AM ET on Thursday Oct 16, 2014 by Accesswire
Companies Mentioned: NBS

New York, NY / October 16, 2014 / NeoStem, Inc. (NASDAQ: NBS) today published a new blog post on The Chairman's Blog, written by the Company's Chairman and CEO, Dr. Robin Smith. TheChairmansBlog.com is an exclusive online media publication that...

Oct 14, 2014

BioLife Solutions Biopreservation Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy
6:00AM ET on Tuesday Oct 14, 2014 by PR Newswire
Companies Mentioned: NBS, BLFS

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife"...

Oct 13, 2014

NeoStem Ranked as One of the Fastest Growing Companies in New York City
7:30AM ET on Monday Oct 13, 2014 by GlobeNewswire
Companies Mentioned: NBS

NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company has been named one of the fastest growing companies from 2010 to 2013 located in the New York City are...

Oct 9, 2014

Pfenex and PATH Partner on Vaccines
5:00PM ET on Thursday Oct 09, 2014 by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and difficult to manufacture proteins, today announced the initiation of a multi-product research program with...

Oct 6, 2014

NeoStem Announces USAN Approval of Generic Name 'Eltrapuldencel-T' for Investigational Patient-Specific Targeted Cancer Immunotherapy
7:30AM ET on Monday Oct 06, 2014 by GlobeNewswire
Companies Mentioned: NBS

NeoStem, Inc. (Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today that the United States Adopted Name Council (USAN) has approved the generic name "eltrapuldencel-T" for the Company's patient-specific targeted canc...

Oct 2, 2014

NeoStem to Present at Multiple October Conferences
4:30PM ET on Thursday Oct 02, 2014 by GlobeNewswire
Companies Mentioned: NBS

NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), will present at multiple upcoming conference...

Pfenex Added to Both Russell Microcap(R) Index and Russell Global Indexes
8:00AM ET on Thursday Oct 02, 2014 by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, today announced that it has been added to both the Russell Microcap(R) Index and the Russell Global Indexes with trading...

Oct 1, 2014

Pfenex to Present at 13th Annual BIO Investor Forum
4:05PM ET on Wednesday Oct 01, 2014 by PR Newswire
Companies Mentioned: PFNX

Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today announced that it will be presenting at the 13th Annual...

NeoStem Establishes Melanoma Scientific Advisory Board to Support Anticipated Phase 3 Trial
10:21AM ET on Wednesday Oct 01, 2014 by GlobeNewswire
Companies Mentioned: NBS

NeoStem, Inc. ("NeoStem" or the "Company," Nasdaq:NBS), a leader in the emerging cellular therapy industry, announced today its establishment of a melanoma scientific advisory board consisting of internationally renowned experts in oncology and...

← Newer12Older →